A multicentre, randomised, placebo-controlled, double-blind comparison with 3 parallel groups to investigate the efficacy and safety of inhaled glucocorticoid Fluticasone (500 µg twice daily via Diskus™) vs. oral glucocorticoid therapy vs. placebo in subjects with chronic obstructive airway disease (COPD ...
fluticasone propionate
Pulmonary Disease, Chronic Obstructive
Phase 4
Datasets from this local German study are no longer available. Following a local legal review of the informed consent form which was used in study we have been advised that, under German law, we are not allowed to anonymise the relevant datasets for this specific study as we did not at the time seek consent for the process of anonymisation. All or some of the documents for this study are in a non-English language. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
September 2013